Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fang

Showing results (1021-1030 of 1,281) with videos related to

Pageof 129
Sort By:
Mucosal Immunology|May 30, 2020
Intestinal epithelium-derived BATF3 promotes colitis-associated colon cancer through facilitating CXCL5-mediated neutrophils recruitmentY Lin, L Cheng, Y Liu, et al.
JACC. Heart Failure|January 4, 2023
Blood Pressure and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: DELIVERSenthil Selvaraj, Muthiah Vaduganathan, Brian L Claggett, et al.
Circulation. Heart Failure|August 29, 2024
Clinical Characteristics and Outcomes of Patients Suffering Acute Decompensated Heart Failure Complicated by Cardiogenic ShockChristos P Kyriakopoulos, Konstantinos Sideris, Iosif Taleb, et al.
Journal of the American Heart Association|February 23, 2024
Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF TrialsAnkeet S Bhatt, Muthiah Vaduganathan, Brian L Claggett, et al.
The American Journal of Medicine|May 5, 2020
Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action InitiativeEbrahim Barkoudah, Gregory Piazza, Todd E H Hecht, et al.
Clinical Transplantation|July 15, 2015
Elevated resting heart rate in heart transplant recipients: innocent bystander or adverse prognostic indicator?S Blake Wachter, Sean P McCandless, Edward M Gilbert, et al.
American Heart Journal|December 21, 2021
Achievement and quality measure attainment in patients hospitalized with atrial fibrillation: Results from The Get With The Guidelines - Atrial Fibrillation (GWTG-AFIB) registryAditya J Ullal, DaJuanicia N Holmes, Barbara L Lytle, et al.
Journal of the American Heart Association|July 11, 2024
Impact of Diabetes and Glycemia on Cardiac Improvement and Adverse Events Following Mechanical Circulatory SupportChristos P Kyriakopoulos, Iosif Taleb, Eleni Tseliou, et al.
Circulation. Heart Failure|June 6, 2022
Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS DatabaseChris J Kapelios, Lars H Lund, Omar Wever-Pinzon, et al.
Circulation. Heart Failure|April 18, 2018
Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure TrialEldrin F Lewis, Brian Claggett, Amil M Shah, et al.
Pageof 129

Showing results (1021-1030 of 1,281) with videos related to

Sort By:
Pageof 129
Mucosal Immunology|May 30, 2020
Intestinal epithelium-derived BATF3 promotes colitis-associated colon cancer through facilitating CXCL5-mediated neutrophils recruitmentY Lin, L Cheng, Y Liu, et al.
JACC. Heart Failure|January 4, 2023
Blood Pressure and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: DELIVERSenthil Selvaraj, Muthiah Vaduganathan, Brian L Claggett, et al.
Circulation. Heart Failure|August 29, 2024
Clinical Characteristics and Outcomes of Patients Suffering Acute Decompensated Heart Failure Complicated by Cardiogenic ShockChristos P Kyriakopoulos, Konstantinos Sideris, Iosif Taleb, et al.
Journal of the American Heart Association|February 23, 2024
Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF TrialsAnkeet S Bhatt, Muthiah Vaduganathan, Brian L Claggett, et al.
The American Journal of Medicine|May 5, 2020
Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action InitiativeEbrahim Barkoudah, Gregory Piazza, Todd E H Hecht, et al.
Clinical Transplantation|July 15, 2015
Elevated resting heart rate in heart transplant recipients: innocent bystander or adverse prognostic indicator?S Blake Wachter, Sean P McCandless, Edward M Gilbert, et al.
American Heart Journal|December 21, 2021
Achievement and quality measure attainment in patients hospitalized with atrial fibrillation: Results from The Get With The Guidelines - Atrial Fibrillation (GWTG-AFIB) registryAditya J Ullal, DaJuanicia N Holmes, Barbara L Lytle, et al.
Journal of the American Heart Association|July 11, 2024
Impact of Diabetes and Glycemia on Cardiac Improvement and Adverse Events Following Mechanical Circulatory SupportChristos P Kyriakopoulos, Iosif Taleb, Eleni Tseliou, et al.
Circulation. Heart Failure|June 6, 2022
Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS DatabaseChris J Kapelios, Lars H Lund, Omar Wever-Pinzon, et al.
Circulation. Heart Failure|April 18, 2018
Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure TrialEldrin F Lewis, Brian Claggett, Amil M Shah, et al.
Pageof 129